EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia

Ayantu Gudina iD, Moges Wordofa iD, Fekadu Urgessa

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0310239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ayantu Gudina und 2 weiteren Autor:innen. Beteiligte Einrichtung: Maychew Health Center, Gulale Sub City, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: HIV Infections, Oxazines, Heterocyclic Compounds, 3-Ring, Pyridones. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immuno-hematological abnormalities are common among HIV infected individuals as well as patients with highly active antiretroviral therapy (HAART). However, the immuno-hematological outcome of Dolutegravir based antiretroviral therapy (ART) usage is not well investigated.

Objectives

To assess hematological and immunological parameters among adult HIV patients before and after initiation of Dolutegravir based ART regimen at St. Peter Specialized Hospital, Addis Ababa, Ethiopia.

Methods

A cross-sectional study was conducted from May to July 2021 at St. Peter Specialized Hospital among adult HIV patients. A total of 422 HIV patients on Dolutegravir based ART (combination of Dolutegravir/lamivudine/tenofovir disoproxil fumarate (DTG/3TC/TDF)) for a minimum of 3 months were selected using convenient sampling methods. Socio-demographic as well as clinical data of the participants was obtained using pre-tested structured questionnaires and a review of medical records. Hematological parameters such as CBC was obtained using Beckman coulter automated hematology analyzer and immunological parameters such as CD4 count were determined using BD FACS presto. Statistical analysis of the data was done using SPSS version 21. Paired t-test was used to compare dependent variables before and after initiation of the new HAART and binary logistic regression was used to determine predictors of immuno-hematological abnormalities. P-value < 0.05 was considered as statistically significant.

Results

Of 422 adult HIV patients, about 273(64.7%) were females. The mean age of study participants was 42.2 years (±10.4SD). The mean white blood cell (WBC) count, red blood cell (RBC) count, hemoglobin (Hb), platelet distribution width (PDW), CD4 count, as well as lymphocyte percentage, neutrophil percentage, and platelet counts (PLT) were increased significantly(P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsOxazinesHeterocyclic Compounds, 3-RingPyridonesPiperazinesAntiretroviral Therapy, Highly ActiveHumansFemaleMaleAdultEthiopiaCross-Sectional StudiesMiddle AgedCD4 Lymphocyte CountAnti-HIV AgentsLamivudineTenofovirYoung AdultHemoglobinsDolutegravir

Substanzen

OxazinesHeterocyclic Compounds, 3-RingPyridonesPiperazinesAnti-HIV AgentsLamivudineTenofovirHemoglobinsDolutegravir

Autor:innen und Institutionen

  • Maychew Health Center, Gulale Sub City, Addis Ababa, Ethiopia.
  • Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

ORCID-Profile: Ayantu Gudina, Moges Wordofa

Zitieren

APA

Gudina, A., Wordofa, M., & Urgessa, F. (2024). Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia. PLOS ONE. https://doi.org/10.1371/journal.pone.0310239

Vancouver

Gudina A, Wordofa M, Urgessa F. Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia. PLOS ONE. 2024. doi:10.1371/journal.pone.0310239

BibTeX
@article{Gudina2024,
  author = {Gudina, Ayantu and Wordofa, Moges and Urgessa, Fekadu},
  title = {Immuno-hematological parameters among adult HIV patients before and after initiation of Dolutegravir based antiretroviral therapy, Addis Ababa, Ethiopia},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0310239}
}
Kostenlos starten →